Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction

Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction

Abstract Aims To evaluate the circulating levels of remodeling biomarkers procollagen type 1 C-terminal propeptide (PICP), human cartilage glycoprotein-39 (YKL-40), plasma renin activity (PRA), aldosterone (Aldo) as well as clinical and echocardiographic parameters in patients with heart failure wit...

Full description

Bibliographic Details
Main Authors: Giovanni Battista Bolla, Antonella Fedele, Andrea Faggiano, Carla Sala, Gloria Santangelo, Stefano Carugo
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Cardiovascular Disorders
Subjects:
Heart failure
Sacubitril/Valsartan
Biomarkers
Fibrosis
Left ventricular ejection fraction
Online Access:https://doi.org/10.1186/s12872-022-02647-0

Internet

https://doi.org/10.1186/s12872-022-02647-0

Similar Items